




 This open-access article distributed under the terms of the Creative Commons Attribution Noncommercial 3.0 License (CC BY-NC 3.0). 
Copyright © 2015 Shahid Beheshti University of Medical Sciences. All rights reserved. Downloaded from: www.jemerg.com 
 
 




Comparison of Oral Midazolam and Promethazine with Oral Midazolam 
alone for Sedating Children during Computed Tomography  
 
Hassan Barzegari, Behzad Zohrevandi, Kambiz Masoumi, Arash Forouzan*, Ali Asgari Darian,  
Shaqayeq Khosravi   
 
Department of Emergency Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 
 
 
*Corresponding Author: Arash Forouzan; Department of Emergency Medicine, Imam Khomeini General Hospital, Ahvaz Jundishapur University of Medical 
Sciences, Azadegan Avenue, Ahvaz, Khuzestan Province, Iran. Postal Code: 6193673166; Tel/Fax: +986112229166; Email: md_89864@yahoo.com 
Received: January 2015; Accepted: March 2015 
 
Abstract 
Introduction: Both midazolam and promethazine are recommended to be used as sedatives in many studies but 
each have some side effects that limits their use. Combination therapy as an alternative method, may decreases 
these limitations. Therefore, this study aimed to compare midazolam with midazolam-promethazine regarding in-
duction, maintenance, and recovery characteristics following pediatric procedural sedation and analgesia. Meth-
ods: Children under 7 years old who needed sedation for being CT scanned were included in this double-blind 
randomized clinical trial. The patients were randomly divided into 2 groups: one only received midazolam (0.5 
mg/kg), while the other group received a combination of midazolam (0.5 mg/kg) and promethazine (1.25 mg/kg). 
University of Michigan Sedation Scale (UMSS) was used to assess sedation induction. In addition to demographic 
data, the child’s vital signs were evaluated before prescribing the drugs and after inducing sedation (reaching UMSS 
level 2). The primary outcomes in the present study were onset of action after administration and duration of the 
drugs’ effect. Results: 107 patients were included in the study. Mean onset of action was 55.4±20.3 minutes for 
midazolam and 32.5±11.1 minutes for midazolam-promethazine combination (p<0.001). But duration of effect was 
not different between the 2 groups (p=0.36). 8 (7.5%) patients were unresponsive to the medication, all 8 of which 
were in the midazolam treated group (p=0.006). Also in 18 (16.8%) cases a rescue dose was prescribed, 14 (25.9%) 
were in the midazolam group and 4 (7.5%) were in the midazolam-promethazine group (p=0.02). Comparing sys-
tolic (p=0.20) and diastolic (p=0.34) blood pressure, heart rate (p=0.16), respiratory rate (p=0.17) and arterial 
oxygen saturation level (p=0.91) showed no significant difference between the 2 groups after intervention. Con-
clusion: Based on the findings of this study, it seems that using a combination of midazolam and promethazine not 
only speeds up the sedation induction, but also decreases unresponsiveness to the treatment and the need for a 
rescue dose. 
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rocedural sedation and analgesia are constantly 
used procedures range from pain-free interven-
tions such as imaging, to painful intervention like 
fracture reduction, wounds care, bone marrow aspira-
tion, and placing a central venous catheter (1, 2). Sedat-
ing the patients, allows them to bear these unpleasant 
procedures while their cardiorespiratory function re-
mains constant. These measures lead to increased qual-
ity of care, patients’ satisfaction, reduced pain and anxi-
ety, and earlier diagnosis and treatment (3-8). Pediatric 
imaging is one of the most indication of procedural seda-
tion and analgesia. In the pediatric patient, performing 
CT scan is stressful and leads to increased mental stress, 
absence of cooperation with the staff, restlessness, and 
anxiety in the patient. These reactions not only interfere 
with the treatments but also lead to changes in physio-
logic parameters such as blood pressure, heart rate, res-
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piratory rate, and etc. (9, 10). Selecting the precise med-
ication is very important in these situations. Using a suit-
able sedative, results in a decrease in the rescue dose and 
increases the safety of the procedure (11). Most of these 
medications can be prescribed through various routes 
and selecting the best drug varies based on the proce-
dure, level of pain, optimum depth of sedation, and the 
patient’s condition (1, 12, 13). Although there are lots of 
drugs that induce conscious sedation, but their side ef-
fects have limited their clinical use (14, 15). Some stud-
ies have suggested using combination therapy as they 
show increased effectiveness, decreased loading dose, 
and therefore decreased side effects (8, 9, 16, 17). 
Midazolam has been used as a sedative in children for a 
long time. This short-acting benzodiazepine acts as a 
sedative, amnesic and stress reliever. It is preferred to 
long-acting benzodiazepines such as diazepam  (18, 19). 
But using oral midazolam alone, shows a high rate of fail-
ure in sedation (20, 21). Promethazine is another agent 
that is used for sedating children (22, 23). It is a common 
antiemetic that has been used as a safe and effective drug 
with a low rate of side effects and failure. Therefore us-
ing it combined with midazolam, may decreases midazo-
lam’s limitations, but to date no study has been done to 
compare the sedative effect of midazolam alone with 
midazolam-promethazine, in children undergoing CT 
scan. For these reasons, this study aimed to compare 
midazolam with midazolam-promethazine regarding in-
duction, maintenance, and recovery characteristics fol-
lowing pediatric procedural sedation and analgesia. 
Methods: 
Study design: 
This double-blind randomized clinical trial was done in 
a medical center in Ahwaz, Iran in 2013. Protocol of the 
study was approved by the ethics committee of Jondisha-
pour University of Medical Sciences, Ahwaz, Iran. The re-
searchers abided by the principles of Helsinki Declara-
tion in the evaluations and prescribing the medications. 
Signed consent forms were obtained from patients’ par-
ents. 
Patients: 
Healthy children under 7 years old who needed sedation 
for undergoing CT scan were included based on Ameri-
can Society of Anesthesiologists (ASA I and II) scale. Ex-
clusion criteria included allergy to midazolam or pro-
methazine, gastritis, any serious systemic disease, se-
vere systemic reaction, severe cardiovascular disease, 
coronary artery disease, head trauma, eye trauma, cen-
tral nervous system disease, contraindications to seda-
tion, receiving sedative-hypnotic drugs in the last 48 
hours. Sampling was consecutive. The sample size was 
determined as 51 patients in each group, considering 
standard deviation range of 3 to 23 minutes for midazo-
lam’s duration of effect (4, 5, 24), with α=0.05 and β=0.1 
and maximum error of 1.5 minutes (d=1.5). 
Intervention: 
Patients were enrolled consecutively and randomly di-
vided into 2 groups: one only received midazolam (a 
dose of 0.5 mg/kg weight), while the other group re-
ceived midazolam (a dose of 0.5 mg/kg weight) plus pro-
methazine (a dose of 1.25 mg/kg weight). Block random-
ization was executed using a computer software. The 
drugs were obtained from Rotexmedica Company (Ger-
many). To ensure that the patients remained unaware of 
the treatment assignment, an hour before CT scan, oral 
promethazine was prescribed for the combination group 
while the other group drank a sugar syrup. 20 minutes 
before the CT scan, both groups received midazolam. All 
the drugs were mixed with fruit juice. In case of vomiting 
in the initial 15 minutes after receiving midazolam, this 
drug would be prescribed again with the same dose. The 
data were gathered by another researcher for ensuring 
blindness to therapy. The drugs were administrated 
when the level of arterial saturated oxygen was above 
95% and in case of any drop in the oxygen saturation, 
oxygen therapy would be started. If the patient didn’t re-
spond to treatment, a rescue dose (50% of the initial 
midazolam dose) would be used. 
Variables: 
Level of sedation was assessed every 10 minutes since 
receiving midazolam based on University of Michigan 
Sedation Scale (UMSS). This scale has 5 levels which is 
shown in panel 1. In addition to demographic data (age, 
sex, weight), the child’s vital signs (respiratory rate, 
heart rate and level of arterial saturated oxygen) were 
evaluated before prescribing the drugs and after induc-
Panel 1: University of Michigan Sedation Scale 
Score Definition 
0  Awake/Alert. 
1 Minimally Sedated: Tired/sleepy, appropriate response to verbal conversation and/or sounds.  
2 Moderately Sedated: Somnolent/sleeping, easily aroused with light tactile stimulation.  
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ing sedation (reaching UMSS level 2). Finally, any side ef-
fect related to the prescribed drugs would be recorded. 
Outcomes: 
The primary outcomes in the present study were onset 
of action after administration and duration of the drugs’ 
effect. To evaluate the onset of action, the time interval 
between midazolam prescription and sedation induction 
(reaching UMSS level 2) was calculated. For evaluating 
the duration of effect, the time interval between sedation 
induction and complete awareness (reaching UMSS level 
0) was recorded. Secondary outcomes included inci-
dence of the drugs’ side effects, heart rate, blood pres-
sure, respiratory rate, arterial oxygen saturation level, 
needing a rescue dose and no response to the treatment 
(not reaching UMSS level 2). 
Statistical analysis: 
The data were entered in SPSS 21.0. Quantitative data 
were expressed as mean ± standard deviation and quali-
tative data were shown as frequency and percentage. To 
compare the 2 groups regarding demographic and clini-
cal factors before intervention chi square test (for nomi-
nal qualitative variables) and Mann-Whitney U test (for 
quantitative and ordinal variables) were used. Also, the 
2 groups were compared regarding onset and duration 
of effect, using Mann-Whitney U test. Since the children’s 
vital signs before intervention was significantly different 
in the 2 groups, non-parametric analysis of covariance 
was used to compare these factors in the groups. In all 




 107 children were included in the study (54 patients in 
the midazolam group and 53 in the midazolam-prometh-
azine group). Mean age was 36.0±15.5 months in the 
midazolam group and 36.8±13.7 months in the midazo-
lam-promethazine group (p=0.79). 31 (57.4%) patients 
in the midazolam group and 28 (52.8%) in the midazo-
lam-promethazine group were male (p=0.63). Table 1 
shows the distribution of demographic and clinical fac-
tors before intervention. As can be seen, only respiratory 
rate was significantly different in the groups (p=0.01). 
Mean onset of action for midazolam (55.4±20.3 minutes) 
was significantly more than midazolam-promethazine 
combination (32.5±11.1 minutes) (p<0.001). But dura-
tion of effect was not different between the 2 groups 
(p=0.36) (figure 1). 8 (7.5%) patients were unresponsive 
to the medication, all 8 of which were in the midazolam 
Table 1: Comparing demographic and clinical factors of the patients before intervention 
Variable Midazolam Midazolam+ Promethazine P 
Age (Month) 36.0 (15.5) 36.8 (13.7) 0.79 
Weight (kg) 14.7 (3.3) 14.2 (2.6) 0.46 
SBP (mm Hg) 97.1 (8.1) 98.9 (5.5) 0.17 
DBP (mm Hg) 59.1 (5.5) 60.6 (3.5) 0.09 
Heart rate (per min) 115.1 (11.1) 112.9 (10.3) 0.29 
Respiratory rate (per min) 19.9 (2.7) 18.8 (2.0) 0.01 





Figure 1: Onset of action (A) and duration of effect (B) of midazolam and midazolam-Promethazine in sedation 
of the children. *, shows significant difference at p<0.001. 
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treated group (p=0.006). Also in 18 (16.8%) cases a res-
cue dose was prescribed, 14 (25.9%) were in the mid-
azolam group and 4 (7.5%) were in the midazolam-pro-
methazine group (p=0.02). Only 2 cases of nausea and 
vomiting was seen both of which were in the midazolam 
group (p=0.99).  
Comparing systolic (p=0.20) and diastolic (p=0.34) 
blood pressure, heart rate (p=0.16), respiratory rate 
(p=0.17) and arterial oxygen saturation level (p=0.91) 
showed no significant difference between the 2 groups 
after intervention (table 2). 
Discussion: 
The findings of this study showed that mean onset of ac-
tion for midazolam is significantly longer compared to 
midazolam-promethazine combination, while their dura-
tion of effect is no different. In addition, the frequency of 
not responding to treatment and needing a rescue dose is 
higher in the midazolam treated group. Yet, both treat-
ments have similar effects on nausea and vomiting, blood 
pressure, heart rate, respiratory rate and arterial oxygen 
saturation level. Therefore, it seems that using a combina-
tion of midazolam and promethazine not only speeds up 
the sedation induction, but also decreases unresponsive-
ness to the treatment and the need for a rescue dose. 
In line with this study, Cengiz et al. showed that the onset 
of action in a combination of midazolam and diphenhy-
dramine is shorter than midazolam alone, while their du-
ration of effect in no different (25). Also, Jain et al. ex-
pressed the same results regarding onset of action com-
paring midazolam-ketamine combination with midazo-
lam (26). In addition, Parkinson et al. (27) and Crean 
(28) demonstrated in their respective studies that pro-
methazine combined with chloral hydrate has a better 
sedative effect on children compared to midazolam 
alone. Houpt et al. showed that using chloral hydrate 
(dose: 25 mg/kg) combined with promethazine, is no dif-
ferent to using a 50 mg/kg chloral hydrate regarding se-
dation level and hemodynamic factors (29). 
In the present study, 2 cases of nausea were seen in the 
midazolam group despite this drug having an antiemetic 
properties, which might be due to its bitter taste. In the 
combination group no nausea and vomiting was seen. 
Since promethazine had been received earlier in this 
group, the anti-histaminic and anti-cholinergic effects of 
promethazine might have controlled the nausea (22). 
The combination treatment using midazolam plus pro-
methazine in children under 7 years old lead to a signifi-
cant decrease in midazolam’s failure and improved its ef-
fectiveness as expected. Midazolam is a short-acting ben-
zodiazepine that exerts its effect by affecting GABA re-
ceptors and resulting in chloride ion influx to the neuron 
(25), while promethazine acts on histamine and cholin-
ergic receptors of medullary reticular formation to show 
its sedative effects (23). Based on the findings of this 
study we can conclude that promethazine amplifies the 
effects of midazolam by affecting medulla and pons and 
leads to a decrease in its failure rate. 
Little sample size and short follow-up time are of the lim-
itations of this study. Therefore it is recommended to in-
crease sample size and follow-up time in future studies. 
Conclusion: 
The findings of this study showed that mean onset of ac-
tion for midazolam is significantly longer compared to 
midazolam-promethazine combination, while their du-
ration of effect is no different. In addition, the frequency 
of not responding to treatment and needing a rescue 
dose is higher in the midazolam treated group. Yet, both 
treatments have similar effects on nausea and vomiting, 
blood pressure, heart rate, respiratory rate and arterial 
oxygen saturation level. Therefore, it seems that using a 
combination of midazolam and promethazine not only 
speeds up the sedation induction, but also decreases un-
responsiveness to the treatment and the need for a res-
cue dose. 
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